Galapagos NV
GLPG
#4558
Rank
A$3.17 B
Marketcap
A$47.66
Share price
-1.20%
Change (1 day)
13.53%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): A-$0.71

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.48. In 2024 the company made an earnings per share (EPS) of A$1.64 a decrease over its 2023 EPS that were of A$5.01.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.71-142.9%
2024A$1.64-67.16%
2023A$5.01-199.64%
2022A-$5.0399.03%
2021A-$2.53-68.98%
2020A-$8.14-298.06%
2019A$4.11-554.64%
2018A-$0.90-77.18%
2017A-$3.96-326.21%
2016A$1.75-134.19%
2015A-$5.12-371.34%
2014A$1.89-445.98%
2013A-$0.5532.88%
2012A-$0.41-82.07%
2011A-$2.29-817.9%
2010A$0.3212.73%
2009A$0.28-120.79%
2008A-$1.36-37.67%
2007A-$2.1839.64%
2006A-$1.5628.17%
2005A-$1.226.25%
2004A-$1.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.72-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.29-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.38-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.91-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.31-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.55-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.32-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.86 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.75-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel